Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate versus etomidate for anesthesia induction in elderly elective surgery patients
ChiCTR2100046482Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and etomidate (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Success rate of anesthesia induction. Started May 2021; status: recruiting.
02
Drugs
remimazolametomidate
Beyond the preview
Go deeper on ChiCTR2100046482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046482.